Fundraising Fox
XII Medical
Union City, US · Founded 2017 · Delaware corporation · 39 employees on LinkedIn · 7 known investors
Find your way into XII Medical
Each arrow is one introduction. Sign up to fill in the first one.
Ask Luke Rohlen to introduce you to Shane Kreidel
You →Luke · together at XII Medical →Shane
Sign up to find every way you can get introduced to XII Medical
- Your email: who you already know at XII Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the XII Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.
Founders & leadership
Board
Investors · 7
How we know: APERTURE Venture Partners's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Broadview Ventures's portfolio page · Not right? Tell us
How we know: CincyTech's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: JobsOhio Ventures's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$45.1M disclosed across 3 rounds · 2020–2024
▶$22.5MraisedAug 2024 · 11 investors · Other Health CareRule 506(b)
- Garrett SchwabExecutive Officer, Director
- Duke RohlenDirector
- JD FriedlandDirector
- Saoussen Ben HalimaDirector
- Shane KreidelExecutive Officer
- Raman GowriDirector
- Tony NataleDirector
- Daniel GottliebDirector
- Offering amount
- $45M
- Amount sold
- $22.5M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedApr 2022 · 12 investors · Other Health CareRule 506(b)
- Garrett SchwabExecutive Officer, Director
- Aftab KheraniDirector
- Zachary EisenDirector
- Tony NataleDirector
- Duke RohlenDirector
- JD FriedlandDirector
- Shane KreidelExecutive Officer
- Raman GowriDirector
- Daniel GottliebDirector
- Offering amount
- $15.1M
- Amount sold
- $15.1M
- Minimum investment
- $4M
- Proceeds to insiders
- $300K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$7.5MraisedApr 2022 · 7 investors · Other Health CareRule 506(b)
- Zachary EisenDirector
- Tony NataleDirector
- Garrett SchwabExecutive Officer, Director
- Duke RohlenDirector
- Daniel GottliebDirector
- Shane KreidelExecutive Officer
- Raman GowriDirector
- Aftab KheraniDirector
- JD FriedlandDirector
- Offering amount
- $15M
- Amount sold
- $7.5M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does XII Medical do?
- XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.
- Who are XII Medical's investors?
- XII Medical's investors include APERTURE Venture Partners, Broadview Ventures, CincyTech, Intuitive Ventures, JobsOhio Ventures, Ajax Health, Omega Funds.
- How much funding has XII Medical raised?
- XII Medical has disclosed $45.1M raised across 3 rounds.
- Where is XII Medical headquartered?
- XII Medical is headquartered in Union City, US.